StreetAlpha.app
Home › Stocks › NTRA

Natera, Inc. (NTRA)

Healthcare
$273.40
▼ −5.70%
LAST CLOSE · NOV 20

Natera is a diagnostics company that offers blood tests for cancer, women's health and organ health. It last closed at $273.40 on Nov 20, down 5.70% on the day. The next earnings report for NTRA is expected around Mon, Jan 11, 2027, after the close. For the quarter ended Sep 2026, NTRA reported EPS of -$0.42 on revenue of $794.0M, with revenue up 34.1% from a year ago. Over its last 8 reports the stock moved an average of 8.4% the session after earnings. Over the last 12 months NTRA insiders bought $0 of stock on the open market and sold $365.6M, according to SEC Form 4 filings.

AI Auto Pilots
Is NTRA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NTRA.

Key Stats

Last 12 months
Results
Revenue
$2.9B
+37.4% vs a year ago
Net income
−$164.7M
−5.7% margin
EPS (diluted)
−$1.12
Free cash flow
$52.5M
1.8% margin
Valuation
Market cap
$39.6B
145.0M shares
P/E
–
No P/E while losing money
Price to sales
13.6
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$1.1B
At Sep 30
Shareholder equity
$1.9B
Shares outstanding
145.0M
At Oct 31
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $625.5M$625.5MFY2021FY2022: $820.2M$820.2MFY2022FY2023: $1.1B$1.1BFY2023FY2024: $1.7B$1.7BFY2024FY2025: $2.3B$2.3BFY2025

From NTRA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · After the close
Reported EPS
-$0.42
Quarter ended Sep 2026
Year ago EPS
-$0.64
Same quarter last year
Revenue
$794.0M
+34.1% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.41Dec '24Mar 2025: -$0.50Mar '25Jun 2025: -$0.74Jun '25Sep 2025: -$0.64Sep '25Dec 2025: $0.36Dec '25Mar 2026: -$0.60Mar '26Jun 2026: -$0.47Jun '26Sep 2026: -$0.42Sep '26Latest -$0.42
Revenue by quarter
Dec 2024: $476.1MDec '24Mar 2025: $501.8MMar '25Jun 2025: $546.6MJun '25Sep 2025: $592.2MSep '25Dec 2025: $665.5MDec '25Mar 2026: $696.6MMar '26Jun 2026: $752.8MJun '26Sep 2026: $794.0MSep '26Latest $794.0M
How NTRA moved after its last 8 reports
Average move the session after a report ±8.4%
Nov 5, 2026After the close−14.6%
Aug 6, 2026After the close+21.4%
May 7, 2026After the close−11.6%
Feb 26, 2026After the close−3.7%
Jan 12, 2026After the close+1.0%
Nov 6, 2025After the close+0.6%
Aug 7, 2025After the close+7.7%
May 8, 2025After the close−6.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on NTRAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on NTRA
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on NTRA

Technical Analysis

NTRA · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, oversold

The stock is 27% below its 20 day and 37% below its 50 day average. It is sitting right on its 200 day average, a level many traders watch. Momentum is weak (RSI 26), oversold. The nearest support is the 200 day average at $273.05, and the nearest resistance the Pivot at $277.88.

Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 7.7%/day
Key levels
$437.4152 week high+60.0%
$375.5250 day average+37.4%
$347.3220 day average+27.0%
$336.17100 day average+23.0%
$283.92Pivot R1+3.8%
$282.00Swing high (Jul 16)+3.1%
$277.88Pivot+1.6%
$273.40Last close
$273.05200 day average−0.1%
$267.37Pivot S1−2.2%
$261.63Swing low (Jul 13)−4.3%
$181.0052 week low−33.8%
Indicators
RSI (14)26.15Oversold below 30Oversold
MACD-28.90Below its signal lineBearish
Stochastic6.1Near the bottom of its rangeOversold
ADX (14)43.3Strong downtrend
Williams %R-98.8Oversold below −80, overbought above −20Oversold
CCI (20)-96.8Oversold below −100, overbought above 100Neutral
Rate of change−12.0%Change over 10 sessionsBearish
ATR (14)$20.96Typical daily range, 7.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for NTRA

What happened before

See how NTRA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow NTRA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How NTRA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for NTRAHow many large options trades hit NTRA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

NTRA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲518 buying vs 392 selling
  • ▼Held by funds -0.8 pts
  • ▲Funds holding +95
  • ▼Superinvestors: 1 added, 7 cut
  • ▼Put/call 0.15 to 3.16
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding947852+11.2%
In funds' top 102721+28.6%
Held by funds93.9%94.7%−0.8 pts
New / increased184 / 334154 / 358+1.2%
Reduced / sold out305 / 87242 / 68+26.5%
Put/call ratio3.160.15+1992.1%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NTRA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

NTRA Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$365.6M125 sales · 12 insiders
86% of the selling was under pre-arranged trading plans.
2025-12 sold $16.0M2026-01 sold $53.8M2026-02 sold $24.7M2026-03 sold $44.9M2026-04 sold $6.7M2026-05 sold $4.4M2026-06 sold $65.0M2026-07 sold $11.8M2026-08 sold $9.9M2026-09 sold $67.9M2026-10 sold $31.6M2026-11 sold $5.4MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 11Jonathan SheenaDirectorSale plan1,500$319.30$479K
Nov 6Jonathan SheenaDirectorSale plan3,150$316.00$995K
Nov 3Michael Burkes BrophyCFOSale plan795$394.97$314K
Nov 2Matthew RabinowitzExecutive ChairmanSale plan748$400.02$299K
Nov 2Jonathan SheenaDirectorSale plan112$399.97$45K
Nov 2Steven Leonard ChapmanCEO And PresidentSale plan3,801$411.80$1.6M
Every insider buy and sale for NTRA over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See NTRA insider trades →

From SEC Form 4 filings by NTRA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NTRA is in one of them and how their past NTRA trades turned out.

NTRA in the AI portfolios
Loading…

NTRA News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NTRA in an article yet. Here's the latest on the wider market.

NTRA in the news

NTRA Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Oct 15
Who traded NTRA · since 2021
Latest 5 filings of 7
$1K – $15KTraded Sep 22, 2025Filed Oct 15, 2025
$1K – $15KTraded Aug 22, 2025Filed Sep 5, 2025
Josh GottheimerSell (partial)
$1K – $15KTraded Jul 22, 2025Filed Aug 11, 2025
$1K – $15KTraded Nov 20, 2024Filed Dec 5, 2024
Dan GoldmanSell (partial)
$1K – $15KTraded Apr 10, 2023Filed May 19, 2023
PersonTypeAmountTradedFiledDelay
Josh GottheimerD · NJBuy$1K – $15KSep 22, 2025Oct 15, 202523 d
Josh GottheimerD · NJBuy$1K – $15KAug 22, 2025Sep 5, 202514 d
Josh GottheimerD · NJSell (partial)$1K – $15KJul 22, 2025Aug 11, 202520 d
Josh GottheimerD · NJBuy$1K – $15KNov 20, 2024Dec 5, 202415 d
Dan GoldmanD · NYSell (partial)$1K – $15KApr 10, 2023May 19, 202339 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Natera

Natera is a diagnostics company based in Austin, Texas, that uses blood tests built on genetic analysis to guide medical decisions. Its tests cover cancer, including Signatera, which tracks disease that may remain or return after treatment, women's health, including prenatal and hereditary cancer screening, and organ health, including transplant rejection and kidney disease. The company sells its tests directly in the United States and through laboratory partners worldwide, serving physicians, patients and cancer researchers.

Headquarters
Austin, TX
Founded
2004